{'fraction_non_alphanumeric': 0.02329450915141431, 'fraction_numerical': 0.009983361064891847, 'mean_word_length': 5.543478260869565, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Risk of volume depletion events with concomitant use of sodium glucose co‐transporter 2 inhibitors and loop diuretics: A self‐controlled case series study

Sodium glucose co‐transporter 2 inhibitors (SGLT2is) are used to prevent cardiovascular complications in type 2 diabetes mellitus (T2DM) and newly indicated to treat heart failure (HF). Loop diuretics are commonly prescribed to manage volume overload in HF and may increase the risk of volume depletion in real‐world practice. This study evaluated the risk of volume depletion following concomitant use of SGLT2is and loop diuretics in veterans.